{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:24:44Z","timestamp":1793784284587,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022850","name":"Myovant Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CS-2018-18-ST2-002"],"award-info":[{"award-number":["CS-2018-18-ST2-002"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.fertnstert.2023.10.031","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T04:35:40Z","timestamp":1698986140000},"page":"95-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals"],"prefix":"10.1016","volume":"121","author":[{"given":"Ali","family":"Abbara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Ufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Voors-Pette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Ezzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Camilo Arjona","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Migoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-4316","authenticated-orcid":false,"given":"Waljit S.","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2023.10.031_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/er.2017-00236","article-title":"Novel concepts for inducing final oocyte maturation in in\u00a0vitro fertilization treatment","volume":"39","author":"Abbara","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.537205","article-title":"Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and Kisspeptin during IVF treatment","volume":"11","author":"Abbara","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/cen.13569","article-title":"Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment","volume":"88","author":"Abbara","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/humupd\/dmac012","article-title":"The LH surge and ovulation re-visited: a systematic review and meta-analysis and implications for true natural cycle frozen thawed embryo transfer","volume":"28","author":"Erden","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molmed.2021.05.008","article-title":"Clinical potential of kisspeptin in reproductive health","volume":"27","author":"Abbara","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib7","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/en.2005-0195","article-title":"Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats","volume":"146","author":"Kinoshita","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.972137","article-title":"Use of kisspeptin to trigger oocyte maturation during in\u00a0vitro fertilisation (IVF) treatment","volume":"13","author":"Sharma","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib9","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2007-1116","article-title":"Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women","volume":"92","author":"Dhillo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib10","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1172\/JCI75730","article-title":"Kisspeptin-54 triggers egg maturation in women undergoing in\u00a0vitro fertilization","volume":"124","author":"Jayasena","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib11","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in\u00a0vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/humrep\/dex253","article-title":"A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a phase 2 randomized controlled trial","volume":"32","author":"Abbara","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/REP-17-0268","article-title":"Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion","volume":"154","author":"Zhai","year":"2017","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib14","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1021\/acs.jmedchem.6b00379","article-title":"Design and synthesis of an investigational nonapeptide KISS1 receptor (KISS1R) agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2(TAK-448), with highly potent testosterone-suppressive activity and excellent water solubility","volume":"59","author":"Nishizawa","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib15","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1210\/jc.2013-4236","article-title":"Sustained exposure to the investigational kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies","volume":"99","author":"MacLean","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib16","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1172\/JCI139681","article-title":"Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders","volume":"130","author":"Abbara","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1159\/000513248","article-title":"Kisspeptin-54 accurately identifies hypothalamic gonadotropin-releasing hormone neuronal dysfunction in men with congenital hypogonadotropic hypogonadism","volume":"111","author":"Abbara","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54313","article-title":"Effects of kisspeptin on sexual brain processing and penile tumescence in men with hypoactive sexual desire disorder: a randomized clinical trial","volume":"6","author":"Mills","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36131","article-title":"Effects of kisspeptin administration in women with hypoactive sexual desire disorder: a randomized clinical trial","volume":"5","author":"Thurston","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1210\/clinem\/dgac117","article-title":"Acute effects of kisspeptin administration on bone metabolism in healthy men","volume":"107","author":"Comninos","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145889","article-title":"Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model","volume":"132","author":"Guzman","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/js.2017-00328","article-title":"Hypothalamic-pituitary-ovarian axis reactivation by Kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea","volume":"1","author":"Millar","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib23","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1172\/JCI63937","article-title":"Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration","volume":"122","author":"Sonigo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib24","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/dez205","article-title":"Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome","volume":"34","author":"Romero-Ruiz","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib25","doi-asserted-by":"crossref","first-page":"E953","DOI":"10.1210\/jc.2013-1569","article-title":"Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54","volume":"99","author":"Jayasena","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib26","first-page":"1039","article-title":"Assessment of dose proportionality: report from the statisticians in the pharmaceutical industry\/pharmacokinetics UK joint working party","volume":"29","author":"Gough","year":"1995","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0015-0282(16)56152-4","article-title":"The pattern of the luteinizing hormone surge in spontaneous cycles is related to the probability of conception","volume":"60","author":"Cohlen","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2015.10.014","article-title":"Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study","volume":"105","author":"Vuong","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/deaa322","article-title":"Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone","volume":"36","author":"Labarta","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib30","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/humrep\/deab031","article-title":"Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study","volume":"36","author":"\u00c1lvarez","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib31","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/humrep\/dex316","article-title":"Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study","volume":"32","author":"Labarta","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.steroids.2015.06.013","article-title":"Random serum progesterone threshold to confirm ovulation","volume":"101","author":"Leiva","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.14202\/vetworld.2017.276-280","article-title":"Effect of kisspeptin on in\u00a0vitro maturation of sheep oocytes","volume":"10","author":"Byri","year":"2017","journal-title":"Vet World"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib34","first-page":"375","article-title":"Effect of different concentrations of kisspeptin on in\u00a0vitro maturation rate of buffalo oocytes","volume":"7","author":"Rajesh","year":"2018","journal-title":"Pharma Innov J"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.fertnstert.2012.12.008","article-title":"Kisspeptin stimulates\u00a0progesterone secretion via the ERK1\/2 mitogen-activated protein\u00a0kinase signaling pathway in rat luteal cells","volume":"99","author":"Peng","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0039-3400966","article-title":"Regulation of pregnancy: evidence for major roles by the uterine and placental kisspeptin\/KISS1R signaling systems","volume":"37","author":"Radovick","year":"2019","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaab060","article-title":"Uterine kisspeptin receptor critically regulates epithelial estrogen receptor \u03b1 transcriptional activity at the time of embryo implantation in a mouse model","volume":"27","author":"Schaefer","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib38","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1210\/clinem\/dgab617","article-title":"Changes in circulating kisspeptin levels during each trimester in women with antenatal complications","volume":"107","author":"Abbara","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.10.031_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.fertnstert.2021.04.031","article-title":"Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester","volume":"116","author":"Abbara","year":"2021","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223019891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223019891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:18:30Z","timestamp":1762150710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028223019891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0015028223019891"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.10.031","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92023 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}